CrossCoat Medical: The Opportunity.
CrossCoat Medical LLC (CCM) has been formed to offer accredited investors an opportunity to invest in a broad array of micro-invasive treatments. Following in the medical device footsteps of ILS’ Rejuve (CCM owns 20% of ILS), these treatments will springboard from the seventeen (17) years of development by Orthopeutics (OLP) to reach into treatment areas such as: Rotator Cuff Repair, Snoring/OSA, Meniscus Repair, Wound Dehiscence, Dermal applications, and others.
Current Round: Pre-Round A. Please contact Lyle Hawkins at 502.419.8099 or .